USPTO Examiner ZAMORY JUSTIN L - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18935426APPARATUSES AND METHODS FOR TRACKING OBSTRUCTIVE MATERIAL WITHIN A SUCTION CATHETERNovember 2024February 2026Allow1530YesNo
18678766MAGNETIC COUPLING THROUGH A STERILE FIELD BARRIERMay 2024August 2025Allow1520NoNo
18640427MEDICAMENT DELIVERY DEVICEApril 2024February 2025Allow911NoNo
18638893SYSTEM AND METHOD FOR SAFETY SYRINGEApril 2024April 2025Allow1200NoNo
18629246SYRINGE ADAPTERApril 2024April 2025Allow1300NoNo
18591453ASSEMBLABLE COMPACT SYRINGE WITH SIDE MOUNTED PLUNGER RODFebruary 2024June 2025Allow1630YesNo
18525267METHOD FOR ROBOTICALLY CONTROLLING SUBSETS OF INTERVENTIONAL DEVICE ASSEMBLYNovember 2023January 2026Abandon2640YesYes
18487796Steerable Microcatheter and Method of UseOctober 2023September 2024Allow1100NoNo
18372770HEMOSTASIS VALVE-EQUIPPED INDWELLING NEEDLE AND INDWELLING NEEDLE ASSEMBLYSeptember 2023April 2025Allow1810NoNo
18465531MICRO-NEEDLE BLADDER BALLOONSeptember 2023October 2025Allow2530NoNo
18233397Microneedles and Methods of Manufacture ThereofAugust 2023March 2025Allow1910NoNo
18446119Drug Device Electroporation Angioplasty SystemAugust 2023February 2025Abandon1910NoNo
18359110DETACHABLE BREAST PUMPJuly 2023February 2024Allow610NoNo
18350712DELIVERY DEVICES FOR DELIVERING AND METHODS OF DELIVERING COMPOSITIONSJuly 2023July 2025Abandon2420NoNo
18329532Apparatuses and method for determining if a catheter is engaged with a blood clotJune 2023September 2024Allow1630YesNo
18329535METHODS FOR REMOVING A BLOOD CLOT MATERIALJune 2023March 2025Allow2220NoNo
18196290MODULAR MEDICAL DEVICE SYSTEMMay 2023October 2025Abandon2920NoNo
18311983Infusion Balloon and Methods for Use ThereofMay 2023November 2024Allow1810NoNo
18299728Guide for intravascular deviceApril 2023January 2026Abandon3330YesNo
18299626AUTOMATIC-SEALING BALLOON-FILLING CATHETER SYSTEMApril 2023November 2024Allow1931YesNo
18193214MULTI-FILAR CATHETER BODY CONSTRUCTIONMarch 2023November 2025Abandon3240NoNo
18117237DEVICES FOR INJECTING MEDICAMENTS AND METHODS OF USEMarch 2023June 2023Allow300NoNo
18099500RELOCATION MODULE AND METHODS FOR SURGICAL EQUIPMENTJanuary 2023May 2023Allow300NoNo
18098531GUIDE EXTENSION CATHETERJanuary 2023October 2024Allow2110NoNo
18094005Venous Access Port Assembly with X-Ray Discernable IndiciaJanuary 2023January 2025Allow2520YesNo
17992115SYRINGE WITH A PATIENT CONTACT SURFACENovember 2022May 2025Allow3030NoNo
17988624SUPPORT STRUCTURENovember 2022August 2024Allow2110NoNo
18053429Epidural Device for Detection of and Needle Placement in Epidural SpaceNovember 2022May 2025Abandon3020NoNo
17885489DUAL NEEDLE DELIVERY SYSTEM THAT CONNECTS AND DEPLOYS NEEDLES OF A MEDICATION DELIVERY DEVICEAugust 2022October 2022Allow210NoNo
17883230Assembly for a Drug Delivery Device and Drug Delivery DeviceAugust 2022February 2025Allow3020NoNo
17880424MEDICAL DEVICE ADAPTERAugust 2022July 2025Abandon3620NoNo
17877731Steerable Microcatheter and Method of UseJuly 2022June 2023Allow1020NoNo
17871053Supplemental Device for Attachment to an Injection DeviceJuly 2022February 2025Allow3020NoNo
17866462APPARATUSES AND METHODS FOR TRACKING OBSTRUCTIVE MATERIAL WITHIN A SUCTION CATHETERJuly 2022February 2023Allow700NoNo
17858053APPARATUSES AND METHODS FOR CONTROLLING REMOVAL OF OBSTRUCTIVE MATERIALJuly 2022March 2023Allow910YesNo
17852247Syringe and Method of UseJune 2022October 2025Allow3910NoNo
17662942CASSETTE FOR A FLOW CONTROL APPARATUSMay 2022June 2024Abandon2510NoNo
17723363CATHETER DEVICES AND METHODS FOR MAKING THEMApril 2022May 2025Abandon3711NoNo
17709125Single-Use Suppository Insertion Device And MethodMarch 2022October 2024Allow3120NoNo
17700719DETACHABLE NEEDLE PROTECTION CAP FOR INJECTION DEVICESMarch 2022September 2024Allow2920NoNo
17637791Epidural Device for Detection of and Needle Placement in Epidural SpaceFebruary 2022August 2022Allow600NoNo
17674639SYRINGE ADAPTERFebruary 2022March 2024Allow2510NoNo
17569572SINGLE ACTUATED PRECISION DOSE INTERMEDIATE PUMPING CHAMBERJanuary 2022April 2025Allow3910YesNo
17566799PROTECTIVE DEVICE FOR THE NEEDLE TUBE OF A SYRINGEDecember 2021May 2023Allow1730YesNo
17556053INNER EAR PLUGDecember 2021June 2024Allow3010NoNo
17596853LIQUID DELIVERY CAP WITH ALIGNMENT VERIFICATIONDecember 2021February 2026Allow5010NoNo
17555458Syringe and Method of UseDecember 2021June 2022Allow510YesNo
17553685PEN NEEDLE ASSEMBLY HAVING AN OUTER COVERDecember 2021August 2024Abandon3210NoNo
17552055HOLLOW SHAFT AND CATHETERDecember 2021July 2025Abandon4310NoNo
17551446SILICONE RUBBER HEATER FOR PERITONEAL DIALYSISDecember 2021December 2025Abandon4810NoNo
17546030MECHANICALLY DRIVEN MEDICATION DELIVERY PATCHDecember 2021April 2022Allow400NoNo
17610813TRIGGERING MECHANISM FOR A MEDICAMENT DELIVERY DEVICENovember 2021May 2025Allow4310NoNo
17524531PERI-VASCULAR TISSUE ABLATION CATHETER WITH SUPPORT STRUCTURESNovember 2021June 2024Allow3110NoNo
17510825DISPOSABLE INJECTION DEVICE WITH LOCKING STRUCTURE TO PREVENT REUSEOctober 2021December 2025Allow4940NoNo
17473098Artificial Pancreas Integrated CGM Architectures and DesignsSeptember 2021November 2025Allow5050YesNo
17467563Cap Assembly for a Medicament Delivery DeviceSeptember 2021January 2025Allow4030NoNo
17403095SYSTEM AND METHOD FOR SAFETY SYRINGEAugust 2021December 2023Allow2810NoNo
17400171MEDICAL INSTRUMENT WITH INTEGRAL NAVIGATION CONTROL FEATURESAugust 2021October 2023Allow2600NoNo
17398119ELECTRIC INJECTION DEVICEAugust 2021April 2025Allow4410NoNo
17395061Assembly for a Drug Delivery Device and Drug Delivery DeviceAugust 2021April 2022Allow910NoNo
17392201Collapsible Syringe Plunger and Syringe Incorporating SameAugust 2021November 2025Allow5150YesNo
17387747Assembly for a Drug Delivery Device and Drug Delivery DeviceJuly 2021January 2022Allow500NoNo
17364546SYSTEM AND METHOD FOR SAFETY SYRINGEJune 2021October 2025Allow5150YesNo
17331438Syringe Having Pivoting Arm Plunger RodMay 2021October 2025Allow5260NoNo
17325375SPRINKLER CANNULAMay 2021July 2023Allow2610NoNo
17294521LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCESMay 2021February 2026Abandon5740NoYes
17293094SUCTION ADAPTOR FOR HIGHLY VISCOUS ENTERAL NUTRIENTMay 2021December 2024Abandon4310NoNo
17289840BALL LOCK ASSEMBLY WITH RETENTION PINApril 2021December 2025Allow5530YesNo
17242085TELESCOPING PLUNGER RODApril 2021June 2023Allow2610NoNo
17288064BIOMEDICAL PRESSURE SENSORApril 2021June 2025Abandon5030NoNo
17286560FLUID TRANSFER DEVICESApril 2021November 2024Abandon4310NoNo
17234206Radial Balloon CatheterApril 2021August 2023Allow2810YesNo
17285656PASSIVE INJECTION DEVICE WITH AUTOMATIC SECURING MEANSApril 2021October 2025Allow5430YesNo
17283954SYRINGE WITH VISUAL INDICATOR AND RETAINING ELEMENTSApril 2021September 2024Abandon4110NoNo
17283602PERSONALIZED DRUG DOSE DISPENSER AND METHODApril 2021December 2024Abandon4410NoNo
17224345BALLOON DILATION CATHETER SYSTEM FOR TREATMENT AND IRRIGATION OF THE SINUSESApril 2021August 2021Allow410YesNo
17301425METHOD AND APPARATUS FOR LOADING A GUIDEWIRE INTO A CONNECTOR WITH A VALVEApril 2021May 2025Abandon4940NoNo
17207878REAGENT-CATALYST DRIVEN SINGLE USE HYDRAULIC DRIVE AND SINGLE USE LARGE VOLUME INJECTORMarch 2021June 2023Allow2710NoNo
17276719PEN NEEDLE APPARATUSMarch 2021November 2024Abandon4410NoNo
17201648DEVICE AND METHOD FOR ASPIRATING BONE MARROWMarch 2021September 2024Abandon4210NoNo
17193598DEVICES AND METHODS FOR DELIVERING POWDERED AGENTSMarch 2021January 2025Allow4630NoNo
17190630SYSTEM AND METHOD FOR PROVIDING IONTOPHORESIS AT TYMPANIC MEMBRANEMarch 2021April 2024Allow3710NoNo
17189185METHOD FOR TREATMENT FOR COMBINATION COLD ATMOSPHERIC PLASMA THERAPY OF SOLID TUMORSMarch 2021October 2024Abandon4310NoNo
17271526ASSISTIVE DEVICE FOR USE WITH A SYRINGEFebruary 2021September 2025Abandon5530YesNo
17167285BALLOON CATHETER INCLUDING A DRUG DELIVERY SHEATHFebruary 2021May 2023Allow2700NoNo
17167721LUER TO LUER TISSUE MORSELIZERFebruary 2021June 2023Allow2800NoNo
17163822DEVICE AND METHOD FOR IDENTIFICATION OF A TARGET REGIONFebruary 2021June 2021Allow410NoNo
17263758Microsensor-based Breastfeeding Volume Measurement DeviceJanuary 2021June 2024Allow4110YesNo
17155575DEVICES, SYSTEMS, AND METHODS FOR OTOLOGYJanuary 2021December 2024Allow4711YesNo
17155564MINIMALLY-INVASIVE TOOLS AND METHODS FOR ACCESSING THE MIDDLE AND INNER EAR THROUGH THE TYMPANIC MEMBRANEJanuary 2021August 2024Allow4330NoNo
17153172SYRINGE WITH A BIDIRECTIONAL PLUNGER ADVANCING MECHANISM FOR A MICRO-DOSING SYRINGE PUMPJanuary 2021December 2022Allow2300NoNo
17151077SYRINGE WITH TWO-STAGE SEALING PRESSUREJanuary 2021September 2025Abandon5640YesYes
17147943Drug Device Electroporation Angioplasty SystemJanuary 2021May 2023Allow2800NoNo
17140448METHODS AND DEVICES FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLEJanuary 2021February 2024Abandon3710NoNo
17136570BALLOON ASSEMBLIES HAVING CONTROLLABLY VARIABLE TOPOGRAPHIESDecember 2020May 2024Abandon4120NoNo
17135866METHOD FOR TREATMENT OF CHOLANGIOCARCINOMA WITH COLD ATMOSPHERIC PLASMA AND FOLFIRINOXDecember 2020June 2025Allow5420NoNo
17121864BALLOON DILATION CATHETER SYSTEM FOR TREATMENT AND IRRIGATION OF THE SINUSESDecember 2020July 2023Allow3110NoNo
17121715THERPEUTIC FLUID DELIVERY CARTRIDGEDecember 2020July 2021Allow710YesNo
16973412INJECTION INSTRUMENT SETDecember 2020May 2025Abandon5330NoNo
15734149METHOD AND SYSTEM OF SENSITIZING CANCER CELLS TO CHEMICAL TREATMENT BY PLASMA BASED ACTIVATIONDecember 2020April 2025Allow5230NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ZAMORY, JUSTIN L.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
6
(75.0%)
Examiner Reversed
2
(25.0%)
Reversal Percentile
41.9%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
40
Allowed After Appeal Filing
6
(15.0%)
Not Allowed After Appeal Filing
34
(85.0%)
Filing Benefit Percentile
17.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 15.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner ZAMORY, JUSTIN L - Prosecution Strategy Guide

Executive Summary

Examiner ZAMORY, JUSTIN L works in Art Unit 3783 and has examined 357 patent applications in our dataset. With an allowance rate of 77.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner ZAMORY, JUSTIN L's allowance rate of 77.9% places them in the 45% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ZAMORY, JUSTIN L receive 2.49 office actions before reaching final disposition. This places the examiner in the 72% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ZAMORY, JUSTIN L is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +12.7% benefit to allowance rate for applications examined by ZAMORY, JUSTIN L. This interview benefit is in the 49% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.8% of applications are subsequently allowed. This success rate is in the 30% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 29.5% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 129.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 84% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.8% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 56.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 32.3% are granted (fully or in part). This grant rate is in the 19% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.5% of allowed cases (in the 84% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.